Glucose (Baxter Healthcare Corporation)
Welcome to the PulseAid listing for the Glucose drug offered from Baxter Healthcare Corporation. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Baxter Healthcare Corporation |
NON-PROPRIETARY NAME: | Dextrose Monohydrate |
SUBSTANCE NAME: | DEXTROSE MONOHYDRATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE |
START MARKETING DATE: | 2017-10-05 |
END MARKETING DATE: | 0000-00-00 |
Glucose HUMAN PRESCRIPTION DRUG Details:
Item Description | Glucose from Baxter Healthcare Corporation |
LABELER NAME: | Baxter Healthcare Corporation |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 2.5(g/50mL) |
START MARKETING DATE: | 2017-10-05 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0338-9547_59d635c6-e46a-4f88-b7e9-e197e6790a87 |
PRODUCT NDC: | 0338-9547 |
APPLICATION NUMBER: | |
Other DEXTROSE MONOHYDRATE Pharmaceutical Manufacturers / Labelers: